Tactile Systems Technology (TCMD) Expected to Announce Earnings on Tuesday

Tactile Systems Technology (NASDAQ:TCMD) is anticipated to release its Q4 2025 results after the market closes on Tuesday, February 17th. Analysts expect the company to announce earnings of $0.44 per share and revenue of $93.7980 million for the quarter. Individuals may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Tuesday, February 17, 2026 at 5:00 PM ET.

Tactile Systems Technology Price Performance

NASDAQ:TCMD opened at $26.45 on Friday. Tactile Systems Technology has a one year low of $8.61 and a one year high of $31.38. The company has a market cap of $590.89 million, a PE ratio of 34.35 and a beta of 0.96. The firm has a 50-day moving average of $29.02 and a 200-day moving average of $20.90.

Wall Street Analysts Forecast Growth

TCMD has been the topic of a number of recent research reports. Wall Street Zen upgraded Tactile Systems Technology from a “buy” rating to a “strong-buy” rating in a report on Saturday, November 1st. Piper Sandler set a $35.00 target price on shares of Tactile Systems Technology in a report on Monday, January 5th. Zacks Research cut shares of Tactile Systems Technology from a “strong-buy” rating to a “hold” rating in a report on Monday, January 5th. Lake Street Capital increased their price objective on shares of Tactile Systems Technology from $23.50 to $32.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Tactile Systems Technology in a report on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Tactile Systems Technology has an average rating of “Moderate Buy” and an average target price of $28.75.

Insider Activity at Tactile Systems Technology

In related news, VP Kristie Burns sold 5,139 shares of the company’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $28.85, for a total transaction of $148,260.15. Following the completion of the sale, the vice president directly owned 72,401 shares in the company, valued at $2,088,768.85. This represents a 6.63% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 2.50% of the stock is currently owned by insiders.

Institutional Trading of Tactile Systems Technology

Institutional investors have recently modified their holdings of the company. Marshall Wace LLP purchased a new position in shares of Tactile Systems Technology during the 4th quarter worth approximately $7,700,000. First Trust Advisors LP lifted its holdings in shares of Tactile Systems Technology by 45.3% during the fourth quarter. First Trust Advisors LP now owns 16,282 shares of the company’s stock valued at $472,000 after purchasing an additional 5,078 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new position in Tactile Systems Technology during the fourth quarter valued at approximately $32,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in shares of Tactile Systems Technology in the fourth quarter worth approximately $36,000. Finally, Wells Fargo & Company MN lifted its position in shares of Tactile Systems Technology by 35.7% during the 4th quarter. Wells Fargo & Company MN now owns 27,022 shares of the company’s stock valued at $784,000 after buying an additional 7,105 shares in the last quarter. 83.43% of the stock is currently owned by hedge funds and other institutional investors.

About Tactile Systems Technology

Tactile Systems Technology, Inc, headquartered in Plymouth, Minnesota, is a medical device company specializing in the design, manufacture and marketing of home-use pneumatic compression therapy systems for the treatment of lymphedema and other chronic edema-related conditions. Using proprietary software and patented pump technologies, the company’s platforms are designed to improve patient outcomes through sequential pressure treatment that promotes fluid mobilization and enhanced lymphatic function.

At the core of Tactile Systems’ product portfolio is the Flexitouch® system, a programmable pneumatic pump and garment system approved for home use, and the Aria® device, which features an intuitive touchscreen interface and advanced garment design.